Statistics for Entera Bio Ltd (id:5990 ENTX)

Valuation metrics

Market cap

58.56M

Enterprise value

53.06M

Trailing P/E (ttm)

-5.13

Forward P/E

-2.89

PEG ratio

-2.89

Price/Sales (ttm)

591.55

Price/Book (mrq)

8.74

Enterprise Value/Revenue

535.98

Enterprise Value/EBITDA

-5.79

Overview

Shares outstanding

36.83M

Float

25.85M

Shares short

44.15K

% Held by insiders

0.19%

% Held by institutions

0.19%

Average volume (10 days)

248.18K

Average volume (90 days)

Price summary

52-Week low

0.52

52-Week high

3.35

52-Week change

55.98%

Beta

1.59

50-Day moving average

1.83

200-Day moving average

1.82

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-7,192.86%

Operational effectiveness

Return on assets

-70.61%

Return on equity

-144.67%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-9,163,000.00

Net income to common (ttm)

-9,178,000.00

Diluted EPS (ttm)

-0.26

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

6.92M

Total cash per share (mrq)

0.19

Total debt (mrq)

309.00K

Total Debt/Equity (mrq)

4.79

Current ratio (mrq)

660.70%

Book value per share (mrq)

0.18

Cash flow

Cash flow statement

-7,968,000.00

Levered free cash flow (LFCF)

-6,336,875.00